MacroGenics, Inc. Obtains $25,000,000 Series D Financing Round
Sep 25, 2008 • Deals • Efren Toscano
Transaction Detail Record
| Company Name | MacroGenics, Inc. |
| Information Release Date | 9/25/2008 |
| Transaction Type | Venture Equity |
| Amount | $25,000,000 |
| Round | Series D |
| Proceeds Purposes | MacroGenics expects to use the proceeds from this financing to fund the cancer stem cell program it acquired through its acquisition of Raven Biotechnologies in July. In addition, the proceeds will be used to further advance the company’s autoimmune, cancer and infectious disease product candidate portfolio, as well as for general working capital purposes. |
| Source |  |
| Transaction Investors | Innovis Investments Alexandria Real Estate Equities, Inc. Alta Partners InterWest Partners OrbiMed Red Abbey Venture Partners Rivervest Venture Partners Ventures West |
